Neuroinflammation refers to the inflammation that occurs in the central nervous system (CNS), involving various cells and molecules of the immune system. While inflammation is a normal response to injury or infection in the body, chronic neuroinflammation can have detrimental effects on brain function and contribute to the pathogenesis of numerous neurological disorders. Microglia, the resident immune cells of the CNS, play a key role in neuroinflammation. When activated, microglia release pro-inflammatory molecules such as cytokines, chemokines, and reactive oxygen species, which can lead to damage of neurons and other cells in the brain. Additionally, astrocytes, another type of glial cell, can become activated and contribute to neuroinflammation. Neuroinflammation has been implicated in a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and traumatic brain injury. In these conditions, chronic inflammation exacerbates neuronal damage and accelerates disease progression. Understanding the mechanisms underlying neuroinflammation is crucial for the development of novel therapeutic strategies. Researchers are exploring various approaches to modulate neuroinflammation, including targeting specific inflammatory molecules, regulating immune cell activation, and promoting neuroprotective pathways. These efforts hold promise for the development of treatments that can slow or halt the progression of neuroinflammatory disorders and promote brain health.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom